Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer

doi:10.3748/wjg.v30.i24.3059

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (670)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

HTML

339

Figures (1-7)

Tables (1-3)

Sum=438

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

115

Sum=181

Publishing Process of This Article

Item

Count

Browse

Download

Sum=25

Jun 28, 2024 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 28, 2024; 30(24): 3059-3075
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3059

Full Size Figure Download Figure

Figure 3 Construction of PII score using the least absolute shrinkage and selection operator-COX regression model. A: Partial likelihood deviance for least absolute shrinkage and selection operator (LASSO) coefficient profiles; B: LASSO coefficient profiles of eight immune and inflammatory related biomarkers; C: Heatmap of correlations of the immune and inflammatory related biomarkers; D: Progression-free survival by prognostic immunoinflammatory index (PII); E: Overall survival by PII. PII: Prognostic immunoinflammatory index; PFS: Progression-free survival; OS: Overall survival.

Citation: Ba ZC, Zhu XQ, Li ZG, Li YZ. Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer. World J Gastroenterol 2024; 30(24): 3059-3075
URL: https://www.wjgnet.com/1007-9327/full/v30/i24/3059.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i24.3059